Doacs
Found 6 free book(s)NICE impact stroke
www.nice.org.ukas direct oral anticoagulants (DOACs), which are also known as non-vitamin k oral anticoagulants (NOACs). DOACs recommended by NICE are apixaban, dabigatran etexilate, edoxaban and rivaroxaban. Anticoagulant prescribing rates in primary care for people with atrial fibrillation at risk of stroke 65% 2015/16 2016/17 2017/18 84%
Guías Europeas 2019 tromboembolismo pulmonar agudo ... - …
scc.org.co3 Se contraindica el uso de DOACs en pacientes con compromiso severo de la función renal, embarazo, lactancia y sindrome antifosfolípido.(recomendación III) Otro tema controversial durante los últimos años ha sido la terapia trombolítica en pacientes con riesgo
Pulmonary Embolism Diagnosis & Treatment Guideline ...
wa.kaiserpermanente.orgof DOACs for long-term use for all patients with PE. Background Pulmonary embolism (PE) is a relatively common vascular disease with potentially life-threatening complications in the short term. The accurate incidence of the condition is unknown, …
Diagnosis and Treatment of Atrial Fibrillation
www.aafp.orgSep 15, 2016 · DOACs: Dabigatran (Pradaxa) Rivaroxaban (Xarelto) Apixaban (Eliquis) Edoxaban (Savaysa) Offer aspirin or aspirin plus clopidogrel (Plavix) Yes No. Cardioversion. Nonemergent. CHA. Atrial Fibrillation.
National Patient Safety Goals Effective July 2020 for the ...
www.jointcommission.org(unfractionated), low molecular weight heparin, warfarin, and direct oral anticoagulants (DOACs). Element(s) of Performance for NPSG.03.05.01 1. The hospital uses approved protocols and evidence-based practice guidelines for the initiation and maintenance of anticoagulant therapy that address medication selection; dosing, including
直接経口抗凝固薬（DOAC）の特徴と使い分け
www.nms.ac.jpantagonist direct oral anticoagulants (DOACs), which has greatly increased treatment options. However, the increased number of options has led to some confusion in the selection of appropriate anticoagulants in specific cases. In this paper, we outline the characteristics of eachindividualDOAC onthe basisof recent reports.